Live Breaking News & Updates on Primary Myelofibrosis

Stay updated with breaking news from Primary myelofibrosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Menarini Industrie Farmaceutiche Riunite: Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis

NEWTON, Mass. and FLORENCE, Italy, Nov. 1, 2022 /PRNewswire/ Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and ....

United States , United Kingdom , Northern Ireland , South Korea , Reshma Rangwala , Selective Inhibitor Of Nuclear Export , Menarini Group , Committee For Orphan Medicinal Products , European Union , Head Of Medical Affairs Oncology , Karyopharm Therapeutics Inc , Drug Administration , European Commission , Exchange Commission , Prnewswire Karyopharm Therapeutics Inc , National Organization Of Rare Diseases , European Medicines Agency , European Economic Area , Chief Medical Officer , Olivia Del Puerto , Medical Affairs Oncology , Orphan Medicinal , National Organization , Rare Diseases , Northern European , Product Characteristics ,

Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis

/PRNewswire/ Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini. ....

United States , United Kingdom , Northern Ireland , South Korea , Menarini Industrie Farmaceutiche Riunite , Reshma Rangwala , Selective Inhibitor Of Nuclear Export , Menarini Group , Committee For Orphan Medicinal Products , European Union , Head Of Medical Affairs Oncology , Karyopharm Therapeutics Inc , Drug Administration , European Commission , Exchange Commission , Prnewswire Karyopharm Therapeutics Inc , National Organization Of Rare Diseases , European Medicines Agency , European Economic Area , Chief Medical Officer , Olivia Del Puerto , Medical Affairs Oncology , Orphan Medicinal , National Organization , Rare Diseases , Northern European ,

Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis

/PRNewswire/ Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group. ....

United States , United Kingdom , Northern Ireland , South Korea , Reshma Rangwala , Selective Inhibitor Of Nuclear Export , Menarini Group , Committee For Orphan Medicinal Products , European Union , Head Of Medical Affairs Oncology , Karyopharm Therapeutics Inc , Drug Administration , European Commission , Exchange Commission , Prnewswire Karyopharm Therapeutics Inc , National Organization Of Rare Diseases , European Medicines Agency , European Economic Area , Chief Medical Officer , Olivia Del Puerto , Medical Affairs Oncology , Orphan Medicinal , National Organization , Rare Diseases , Northern European , Product Characteristics ,

Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis

/PRNewswire/ Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group. ....

United States , United Kingdom , Northern Ireland , South Korea , Reshma Rangwala , Selective Inhibitor Of Nuclear Export , Menarini Group , Committee For Orphan Medicinal Products , European Union , Head Of Medical Affairs Oncology , Karyopharm Therapeutics Inc , Drug Administration , European Commission , Exchange Commission , Prnewswire Karyopharm Therapeutics Inc , National Organization Of Rare Diseases , European Medicines Agency , European Economic Area , Chief Medical Officer , Olivia Del Puerto , Medical Affairs Oncology , Orphan Medicinal , National Organization , Rare Diseases , Northern European , Product Characteristics ,

Narayana Health initiates Phase II Clinical Trial of CAR-T

Bengaluru (Karnataka) [India], October 20 (ANI/NewsVoir): Narayana Health, one of the leading healthcare chain in India, today announced that they have offered support to Immuneel Therapeutics, to build the most advanced CAR-T cell laboratory at the Narayana Health city Bengaluru ....

Cayman Islands , Emmanuel Rupert , Sikandar Bakht , Devi Shetty , Sharat Damodar , Amyra Sikandar Khan , Nh Health City , Narayana Health City , Narayana Health , Oncology Services Collegium , Immuneel Therapeutics , Multiple Myeloma , Amyra Sikandar , Bone Marrow Transplant , Cricket Commentator , Managing Director , Lymphoblastic Leukemia , Myeloproliferative Neoplasms , Primary Myelofibrosis , Aplastic Anaemia , Sickle Cell , Oncology Collegium , Clinical Director , Adult Haematology , Bone Marrow Transplant Unit , Vice Chairman ,